Malnique, F. et al. 2025. USE OF DAPAGLIFLOZIN (FORXIGA) IN THE MANAGEMENT OF OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES. LUMEN ET VIRTUS. 16, 54 (Nov. 2025), e10045 . DOI:https://doi.org/10.56238/levv16n54-080.